Sort
23,748 grants matching “melanoma”
Novel Immunologic Effects of Semaphorin 7a in IPF
$415,176Erica L Herzog · Yale University · R01 · FY2012 · HL
SOUTHWEST ONCOLOGY GROUP CA-13612
$415,058University Of Arizona · U10 · FY2000 · CA
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
$415,046Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
$415,045Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
ATF2 in melanoma development and progression
$415,041Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
ATF2 in melanoma development and progression
$415,041Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2009 · CA
Transplanting Unique Human Microbiomes to Improve Immunotherapy in Glioblastoma
$415,031Braden Cox McFarland · University Of Alabama At Birmingham · R21 · FY2021 · CA
UV damage, repair, and mutagenesis
$415,000Gerd P Pfeifer · Beckman Research Institute/City Of Hope · R37 · FY2009 · ES
Mechanisms of Junctional Proteins in Post-Surgical Lymphedema
$414,996Aladdin Hasan Hassanein · Indiana University Indianapolis · R01 · FY2025 · HL
ATF2 in melanoma development and progression
$414,988Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2006 · CA
Targeting the Rac1 signaling pathway in malignant melanoma
$414,929Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · R01 · FY2019 · CA
Hedgehog signaling in head and neck cancer stem cells, and its role in resistance
$414,711Antonio Jimeno · University Of Colorado Denver · R01 · FY2012 · CA
Structure-guided cancer immunotherapy design with HLA-Arena and CrossDome
$414,649Dinler Antunes · University Of Houston · R21 · FY2024 · CA
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy
$414,525Aaron Michael Ring · Yale University · P50 · FY2024 · CA
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma
$414,525Qin Yan · Yale University · P50 · FY2024 · CA
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss
$414,483Tal Teitz · Creighton University · R01 · FY2022 · DC
Analysis of Glycomic Regulators in Melanoma Progression
$414,427Charles J Dimitroff · Florida International University · U01 · FY2020 · CA
Mechanism-based strategies to target oncogenic BRAF signaling
$414,404Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
ISG15 and Protein ISGylation in Cancer
$414,306Dong-Er Zhang · University Of California, San Diego · R01 · FY2021 · CA
Project 2: The Impact of Immunotherapy on Human Vaccination
$414,295E. John Wherry · Massachusetts General Hospital · U19 · FY2019 · AI
Biochemistry of Melanins and Photoprotection of the Skin
$414,252Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The Regulation of Mammalian Pigmentation
$414,252Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$414,188Yin Wang · University Of Maryland Baltimore · R01 · FY2021 · CA
Role of Polo-Like Kinase-1 in Melanocytic Transformation
$414,108Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2016 · AR
Regulation of TCF3 by Wnt signaling
$414,063Sergei Y Sokol · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · GM